Seaford Pharmaceuticals
Transforming Pharmaceutical Marketing in Canada

The world needs more pharmaceutical companies to expand into international markets for better access to life-saving drugs. However, with the complex regulatory frameworks set by governments, obtaining market authorization for prescription drugs can be a challenge. Seaford Pharmaceutical understands this and has complemented its extensive knowledge of the Canadian market with a comprehensive network of suppliers and manufacturers so companies from around the globe can introduce cutting-edge therapeutic products to the market.

“Our deep understanding of healthcare requirements, combined with the support of industry key opinion leaders, gives us a competitive edge. Our company provides products primarily for healthcare professionals in Canada,” says Tamara Seales, president of Seaford Pharmaceuticals.

Seaford specializes in developing niche healthcare products primarily targeting the requirements of the Canadian public. Its portfolio comprises many products across various therapeutic areas, including women’s health, anemia, digestive health, and skincare. Through collaborative research with clinical specialists, Seaford has developed Hemaforte and Lomelin, which treat iron deficiency anemia and hyperpigmentation.

Seaford has introduced many firsts in the therapeutic space and is known widely for launching a unique calcium treatment for osteoporosis. Since then, it has ventured into other medical sectors, including introducing clinically proven probiotics to treat gastrointestinal disorders. Currently, Seaford’s product range spans a variety of therapeutic areas, including hospital products. .

Adhering to Health Canada’s stringent regulations, Seaford ensures the products it manages are developed and released by employing stellar regulatory affairs and a marketing department that is always up-to-date with the latest drug regulations.

Collaborating with numerous medical practitioners including dermatologists, nephrologists, gastroenterologists, and family physicians through its sales representatives enables Seaford to obtain valuable feedback and improve its products. Focusing on nephrology and urology, for instance, Seaford promotes potassium citrate, a supplement for hypokalemia that stabilizes potassium levels in patients. The medical liaison team worked with a highly respected physician who taught at University of Toronto, to fill the knowledge gap among his community on kidney stone treatment. Seaford collaborated with him to create a primer on kidney stones that is used widely for physician education.

Besides developing products, Seaford is heavily committed to giving back to the community and providing free healthcare to the needy. A case in point, it funded the construction of a pediatric clinic in Kingston, Jamaica through its partnership with a pediatric association in 2021. Seaford’s efforts continue to help alleviate problems related to primary healthcare in the area.

To curb interruptions caused by the epidemic, Seaford adopted omnichannel marketing strategies to communicate with health care providers through offline and online channels. Consequently, it overcame the healthcare sector’s medical care shortage and COVID-related supply chain problems. Seaford is a family-run business that provides quality products and maintains a healthy work environment. It gives extensive training to new employees on the basics of the pharmaceutical industry, product knowledge, and job-specific skills to ensure a competent and professional workforce. Seaford implements a hybrid work culture where employees can work remotely and/ or in person. Riding on the experience of its leadership team, Seaford provides specialty healthcare solutions to pharmacists, specialists, and family physicians. It is currently expanding its hospital division and export its products internationally while staying dedicated to creating cuttingedge therapeutic products and making a difference in the industry.